Join endpoint Clinical experts, Vincent Puglia, Senior Director, Strategic Alliances, and Garen Avetissyan, Sr. Director, Business Intelligence & Analytics as they discuss with Immuto’s co-founders Derek Strauss, COO, and Sebastian Coates, CEO how blockchain can improve IRT processes that provide benefits beyond IRT. Blockchain’s tamper-proof audit trails for any kind of data that has high data integrity and accountability to securely connect stakeholders in clinical trials across sponsors, vendors, sites, monitors, and regulators; facilitating trust and collaboration in the clinical research space leading to higher efficiency in the clinical research space.
What you will learn:
- What is blockchain?
- Randomization verification and attestation using blockchain
- Streamlined patient file management through blockchain
- Distributed Integration/Integrated Distribution with blockchain
Contact us to discuss this topic further.
Vincent Puglia
Sr. Director, Strategic Alliances at endpoint
Vincent is a life-long operations and business management professional with a 24-year career across construction, environmental science, technology, and pharmaceuticals.
Vincent provides leadership at the nexus of building relationships, innovating technology, and driving collaborative efforts to design, build and grow systems of all types and complexity in the real and digital world in the service of patients and clinical trials.
Garen Avetissyan
Sr. Director, Business Intelligence & Analytics at endpoint
Garen started his career in life sciences and health research industries in 1996, working in IT, clinical data management, drug safety, and IRT areas. His IRT experience includes both provider and sponsor sides; leading projects, data management, application support teams, standards and processes, governance, and analytics. He joined endpoint Clinical in 2015, first leading the Services and later the Product Engineering teams. Currently, he heads the Business Intelligence and Analytics unit at endpoint. Garen has a Bachelor of Science in applied mathematics and a Master of Business Administration.
Sebastian Coates
CEO & Co-Founder Immuto
Sebastian received degrees in computer science and mathematics from Tufts University where he focused on security and interpretable machine learning.
He has worked in enterprise blockchain at Bank of America and Vertex Pharmaceuticals. At Apple, Sebastian worked at the intersection of health and technology on the Watch team, applying machine learning to build personalized user experiences.
Derek Strauss
COO & Co-Founder Immuto
Derek has a background in both business and technology. He received a degree in Finance from Florida State University. During his time at Florida State he helped co-found a technology conference with over 250 attendees. Prior to Immuto, he worked at Vertex Pharmaceuticals where he researched and helped develop a Proof of Concept Blockchain application for clinical trials. Following this, he was a Technology Consultant at EY where he worked with clients in the agriscience industry on a blockchain initiative.